Offer extended until 31 July 2026: get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
Ph. Eur. Glass Containers
Recommendation
4/5 November 2026
How to avoid Mix-Ups, Contamination and labelling issues
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Ph. Eur. chapter 3.2.1. Glass containers for pharmaceutical use has been revised (Issue 13.2). The chapter will become effective as from 1 April 2027.
Chapter Changes
- A clarification has been added to describe the purpose of tests A, B and C, used to define the glass type and characterise the hydrolytic resistance of the glass.
- Hydrolytic resistance: Table 3.2.1-1 has been modified to provide more detailed information about each test and its purpose.
- Spectral transmission for coloured glass containers: The approach for determining the maximum transmission limit has been modified. The light protection or resulting light transmission of a coloured glass depends (among others) on the wall thickness of the containers. Therefore, it was decided to base the maximum spectral transmission determination and corresponding specifications for containers for parenteral preparations on the wall thickness instead of the volume.
More informaton is avalable in the European Pharmacopoeia Online (a licence is needed).
Related GMP News
22.07.2026Recycled Packaging for Pharma?
22.07.2026Proposal for New Ph. Eur. Chapter on Prefillable Syringes
13.05.2026Proposed Revisions to USP's Glass Chapters
22.04.2026Roadmap for the Introduction of the Electronic Package Leaflet
15.04.2026Revision of Ph. Eur. Chapter on Extractables in Plastic Materials